9 Retinitis Pigmentosa Clinical Trials in Chicago, IL (2026)

Q: Are there retinitis pigmentosa clinical trials in Chicago?

Yes, there are 9 retinitis pigmentosa clinical trials currently recruiting in Chicago, IL.

Q: How do I join a clinical trial in Chicago?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you.

Q: Are clinical trials in Chicago free?

Yes, clinical trial participation is always free. Study-related treatments, medical tests, and doctor visits are provided at no cost.

Recruiting Retinitis Pigmentosa Studies in Chicago

NCT01561157Recruiting

Longitudinal Study of the Porphyrias

The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pregnancy outcomes, and mortality in peopl...

Chicago, IL1,500 participantsThe American Porphyrias Expert Collaborative

View Study Details

NCT04715139Recruiting

Evaluate the Continued Safety and Performance of the Foot and Ankle Products

The objective of the registry is to evaluate the continued safety and performance of Arthrex foot and ankle products, including the ProStop® implant for hyperpronated foot; Bio-Compression Screw for r...

Chicago, IL700 participantsArthrex, Inc.

View Study Details

NCT07159841Recruiting

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of atumelnant treatment in pediatric participants with classic congenital adrenal hyperp...

Chicago, ILPHASE2153 participantsCrinetics Pharmaceuticals Inc.

View Study Details

NCT07144163Recruiting

A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia

The purpose of this study is to evaluate the efficacy, safety, PK, and PD of atumelnant in adults with classic CAH due to 21-OHD....

Chicago, ILPHASE3150 participantsCrinetics Pharmaceuticals Inc.

View Study Details

NCT05783245Recruiting

Effect of Cooling Therapy for Post-Operative Pain in Open Carpal Tunnel Release

This study seeks to perform an appropriately-powered study to evaluate any clinical difference between continuous cooling therapy and traditional ice for treatment of post-operative pain in open CTR s...

Chicago, ILNA128 participantsUniversity of Chicago

View Study Details

NCT06224218Recruiting

Prostate Single Port & Laser Enucleation Comparison Trial

Surgical treatments for benign prostatic hyperplasia (BPH) are necessary when non-procedural approaches fail to alleviate lower urinary tract symptoms (LUTS) or bladder outlet obstruction (BOO). Open ...

Chicago, ILNA116 participantsUniversity of Illinois at Chicago

View Study Details

NCT07551921Recruiting

PheCheck™ Validation Study

The goal of this observational study is to evaluate the performance of the PheCheck™ test for the rapid detection of phenylalanine (Phe) from a fingerstick sample, in patients 1 year or older with phe...

Chicago, IL60 participantsAptatek BioSciences, Inc

View Study Details

NCT04909138Recruiting

Intermittent Dosing of Dorsal Root Ganglion Stimulation as an Alternate Paradigm to Continuous Low-Frequency Therapy

This study seeks to evaluate the use of intermittent dosing as an alternative paradigm for patients with DRG stimulation in place for at least 1 year and minimum 50% pain relief in the targeted area. ...

Chicago, ILNA30 participantsRush University Medical Center

View Study Details

NCT07536269Recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old

The main objective of this study is to assess the safety and tolerability of crinecerfont in pediatric participants 3 months to \<4 years of age with CAH....

Chicago, ILPHASE220 participantsNeurocrine Switzerland GmbH

View Study Details

About Retinitis Pigmentosa Clinical Trials in Chicago

Retinitis pigmentosa (RP) is a group of inherited retinal diseases that cause progressive loss of photoreceptor cells in the retina, leading to vision loss. It typically begins with night blindness and progresses to tunnel vision. Gene therapy and retinal implants are areas of active research.

There are currently 9 retinitis pigmentosa clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 2,857 participants. Research is being sponsored by The American Porphyrias Expert Collaborative, Arthrex, Inc., Crinetics Pharmaceuticals Inc. and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Retinitis Pigmentosa Clinical Trials in Chicago — FAQ

Are there retinitis pigmentosa clinical trials in Chicago?

Yes, there are 9 retinitis pigmentosa clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chicago?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.

Are clinical trials in Chicago free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.

What retinitis pigmentosa treatments are being tested?

The 9 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for retinitis pigmentosa.

Data updated October 12, 2026 from ClinicalTrials.gov